European Commission allows Glycom A/S to place lacto-N-tetraose (‘LNT’), obtained by microbial fermentation with a genetically modified strain of Escherichia coli, strain K12 DH1, on the Union market as a novel food. CLICK HERE Tags: HMO, LNT, novel food Read more articles Previous PostFermented Food Consumption Associated with Changes in the Gut Microbiome Next PostThe Global Prebiotic Association Welcomes FrieslandCampina Ingredients as a New Member You Might Also Like Prebiotics and Sports Nutrition August 30, 2022 Prebiotics and impact on resilience to circadian rhythms disruptions September 20, 2021 Active Vitamin D Levels Linked to Gut Microbiome November 26, 2020